Chris Stix is an equity investor and former sell side analyst. Since leaving Morgan Stanley in 2002, Chris has been managing a portfolio, primarily focusing on global asset allocation. Previously, he was head of global communications equipment research at SG Cowen. From 2003 to 2010 Chris was an Overseer and Trustee at the Joslin Diabetes Center. During this period, he chaired the Clinic Committee and served on the investment, finance, executive and governance committees. He continues to serve on Joslin’s Investment Committee. Chris has a BA from the University of Wisconsin and was awarded an MBA with High Distinction from the Harvard Graduate School of Business Administration in 1981.